Hemophilia

Pic:gettyvirusowy

FDA approves once-weekly hemophilia A therapy

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved Sanofi and Sobi’s Altuviiio (efanesoctocog alfa): a first-in-class, high-sustained factor VIII replacement therapy.

Pic:gettyismagilov

EU approves first gene therapy for hemophilia B

By Jonathan Smith

Three months after receiving the US green light, CSL’s candidate Hemgenix has become the first gene therapy to gain EU approval for the treatment of hemophilia B.

Spotlight

Follow us

Products

View more

Featured Suppliers

All